Daily Sepsis Research Analysis
Three studies advance precision sepsis care: plasma proteomics defined mechanistic sepsis subtypes with distinct immune signatures and built a minimal-protein classifier; a 13,888-patient analysis revealed a nonlinear link between admission lactate and ICU mortality with a critical threshold near 6.1 mmol/L; and an externally validated nomogram predicted sepsis risk in acute liver failure, outperforming SOFA and SIRS.
Summary
Three studies advance precision sepsis care: plasma proteomics defined mechanistic sepsis subtypes with distinct immune signatures and built a minimal-protein classifier; a 13,888-patient analysis revealed a nonlinear link between admission lactate and ICU mortality with a critical threshold near 6.1 mmol/L; and an externally validated nomogram predicted sepsis risk in acute liver failure, outperforming SOFA and SIRS.
Research Themes
- Molecular subtyping and proteomic biomarkers for precision sepsis care
- Nonlinear prognostication and actionable thresholds (lactate)
- Disease-specific risk prediction models with external validation (acute liver failure)
Selected Articles
1. Plasma proteomics identifies molecular subtypes in sepsis.
In a prospective multi-center cohort (n=333), LC–MS/MS plasma proteomics identified four sepsis subtypes with distinct clinical severity and immune features. One cluster had 100% mortality, while others differed in adaptive vs acute inflammatory signatures and immunoglobulin levels. A machine-learning classifier using 10 proteins plus Ig quantities accurately assigned patients to subtypes for potential trial enrichment.
Impact: This study delivers mechanistic subtyping tied to outcomes and provides a feasible minimal-protein classifier, a key step toward precision sepsis trials and targeted therapies.
Clinical Implications: Proteomic subtyping could enable early stratification, personalized immunomodulation, and predictive enrichment in sepsis trials. A pragmatic 10-protein+Ig panel may be adapted to routine diagnostics after validation.
Key Findings
- Four proteome-defined sepsis subtypes were identified, spanning a severity gradient; one cluster showed 100% mortality.
- Subtypes exhibited distinct immune signatures: adaptive immunity activation with elevated immunoglobulins vs acute inflammation with lowest Ig levels, corroborated by orthogonal assays.
- A random-forest classifier using 10 proteins plus immunoglobulin quantities accurately assigned patients to clusters 1–3, enabling potential diagnostic implementation.
Methodological Strengths
- Prospective multi-center cohort with day 1 and day 4 sampling
- Integrated LC–MS/MS proteomics with clinical data, cytokines, and orthogonal Ig validation; parsimonious ML classifier
Limitations
- Generalizability beyond the studied cohort and settings is unproven; no interventional validation
- Classifier optimized for clusters 1–3; longitudinal dynamics and external clinical implementation remain to be tested
Future Directions: Validate the 10-protein+Ig panel across diverse cohorts, develop a clinical-grade assay, and design subtype-enriched interventional trials.
BACKGROUND: The heterogeneity of sepsis represents a significant challenge to the development of personalized sepsis therapies. Sepsis subtyping has therefore emerged as an important approach to this problem, but its impact on clinical practice was limited due to insufficient molecular insights. Modern proteomics techniques allow the identification of subtypes and provide molecular and mechanistical insights. In this study, we analyzed a prospective multi-center sepsis cohort using plasma proteomics to describ
2. Non-linear Association Between Lactate Levels and ICU Mortality in Septic Patients: A Multi-Center Study of 13,888 Cases.
Using 13,888 eICU sepsis cases, admission lactate showed a nonlinear association with ICU mortality with a critical threshold around 6.09 mmol/L. Patients in the highest lactate quartile (>5.2 mmol/L) had a 133% higher adjusted mortality risk versus <2.0 mmol/L. Results were robust across most subgroups, with interactions for acute respiratory failure and mechanical ventilation.
Impact: Defines an actionable lactate threshold and quantifies risk beyond linear assumptions, refining triage and escalation decisions in sepsis.
Clinical Implications: A lactate threshold near 6 mmol/L may trigger early escalation (e.g., resuscitation intensity, monitoring) and inform prognostic counseling. Integrating lactate with respiratory failure and ventilation status can further tailor risk.
Key Findings
- Admission lactate had a nonlinear relationship with ICU mortality; a critical threshold was identified at approximately 6.09 mmol/L.
- Highest lactate quartile (>5.2 mmol/L) was associated with a 133% increased adjusted mortality risk vs the lowest quartile (<2.0 mmol/L).
- Associations were consistent across subgroups without significant interactions except for acute respiratory failure and mechanical ventilation.
Methodological Strengths
- Large multi-center cohort (n=13,888) with extensive covariate adjustment
- Threshold effect and subgroup interaction analyses to capture nonlinearity
Limitations
- Retrospective database study with potential residual confounding and measurement variability
- Single admission lactate; kinetics and time-updated measures were not analyzed
Future Directions: Prospective validation of threshold-guided care pathways and incorporation of lactate kinetics into dynamic prognostic models.
BackgroundBlood lactate is a crucial prognostic indicator in sepsis, but its non-linear relationship with mortality remains unclear. This study aimed to investigate the complex association between lactate levels and ICU mortality in septic patients.MethodsIn this multi-center retrospective study of 13,888 septic patients from the eICU database, we analyzed the association between admission lactate levels and ICU mortality using multivariate models and threshold effect analysis. Models were adjusted for de
3. Dynamic nomogram predicts sepsis risk in patients with acute liver failure: Analysis of intensive care database with external validation.
Using 738 ALF patients (MIMIC-IV and an external Chinese cohort), a logistic regression-based nomogram (SIALF) predicted sepsis risk with strong discrimination and calibration, outperforming SOFA and SIRS. Internal bootstrapping and external validation supported robustness; an online calculator enables bedside use.
Impact: Provides a disease-specific, externally validated tool that surpasses standard scoring for early sepsis risk identification in ALF, enabling targeted monitoring and intervention.
Clinical Implications: Clinicians can apply the SIALF nomogram to triage ALF patients for early sepsis surveillance and preemptive therapies, potentially improving outcomes compared with SOFA/SIRS-based approaches.
Key Findings
- A dynamic nomogram (SIALF) built from MIMIC-IV and externally validated in FMCPH accurately predicted sepsis in ALF.
- The model outperformed SOFA and SIRS in discrimination and showed good calibration and net clinical benefit by decision curve analysis.
- Internal bootstrapping and external validation demonstrated robustness; an online calculator facilitates clinical use.
Methodological Strengths
- Internal bootstrapping and external cohort validation
- Comprehensive performance assessment (AUC, calibration, decision curve); online calculator for implementation
Limitations
- Retrospective design with potential selection bias and missingness
- External validation limited to a single center; generalizability to other settings remains to be tested
Future Directions: Prospective multi-center validation, EHR integration with real-time alerts, and impact analysis on clinical outcomes when guiding early interventions.
BACKGROUND: Acute liver failure (ALF) with sepsis is associated with rapid disease progression and high mortality. Therefore, early detection of high-risk sepsis subgroups in patients with ALF is crucial. AIM: To develop and validate an accurate nomogram model for predicting the risk of sepsis in patients with ALF. METHODS: We retrieved data from the Medical Information Mart for Intensive Care (MIMIC) IV database and the Fifth Medical Center of Chinese PLA General Hospital (FMCPH). Univariate and multivariate logistic regression analysis were used to identify risk factors for sepsis in ALF and were subsequently incorporated to construct a nomogram model [sepsis in ALF (SIALF)]. The discrimination ability, calibration, and clinical applicability of the SIALF model were evaluated by the area under receiver operating characteristic curve, calibration curves, and decision curve analysis, respectively. The Kaplan-Meier curves were used for robustness check. The SIALF model was internally validated using the bootstrapping method with the MIMIC validation cohort and externally validated by the FMCPH cohort. RESULTS: A total of 738 patients with ALF patients were included in this study, with 510 from the MIMIC IV database and 228 from the FMCPH cohort. In the MIMIC IV cohort, 387 (75.89%) patients developed sepsis. Multivariate logistic regression analysis revealed that age [odds ratio (OR) = 1.016, 95% confidence interval (CI): 1.003-1.028, CONCLUSION: Based on easily identifiable clinical data, we developed the SIALF model to predict the risk of sepsis in patients with ALF. The model demonstrated robust predictive efficiency, outperformed Sequential Organ Failure Assessment and systemic inflammatory response syndrome scores, and was validated in an external cohort. The model-based risk stratification and online calculator might further facilitate the early detection and appropriate treatment for this subpopulation.